Envoy Medical completes enrollment for fully implanted cochlear trial

May 11, 2026 8:02 AM

Envoy Medical Inc. (NASDAQ: COCH) completed enrollment of 56 patients in its pivotal clinical trial for the Acclaim cochlear implant ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found